TMP is widely used in the clinical therapy of ischemic cerebral and myocardial diseases in China, and whole-blood viscosity and platelet aggregation are used as prognostic indicators; the CXCR4/SDF-1 interaction is involved in these processes [24]–[25]. The gene discussed is CXCR4; the disease is myocardial disorder.